Medi-Caps Peer Comparison
NSE: MEDICAPS | BSE: 523144
₹25.82
As on 18-Sep-2026IST
Market cap
₹32 Cr
Revenue (TTM)
₹13 Cr
P/E Ratio
--
P/B Ratio
0.3
Div. Yield
0 %
| Medi-Caps | Entero Health | Pentokey Organy | Maitri Enterprises | Rubra Medicaments | |
|---|---|---|---|---|---|
Market cap (₹ Cr) |
32 | 7,543 | 21 | 17 | 16 |
Revenue (₹ Cr) |
13 | 7,128 | -3 | 32 | 562 |
Net Profit (₹ Cr) |
-1.78 | 167.66 | -0.07 | 0.84 | 1.24 |
Net Margin (%) |
-8.71 | 2.35 | 2.62 | 2.62 | 0.22 |
RoE (%) |
-1.56 | 7.58 | -0.66 | 17.29 | 9.81 |
Price to Earnings |
-- | 60.15 | -- | 19.69 | 13.23 |
Price-To-Book |
0.29 | 4.35 | 2.09 | 3.44 | 8.68 |
Income Statement (₹ Cr)
| Medi-Caps | Entero Health | Pentokey Organy | Maitri Enterprises | Rubra Medicaments | |
|---|---|---|---|---|---|
|
Operating Revenue
|
12.45 | 6,591.21 | 0.83 | 28.66 | 0.50 |
|
Total Income
|
20.66 | 6,610.45 | 1.29 | 28.70 | 0.50 |
|
Total Expenditure
|
21.85 | 6,325.26 | 1.04 | 26.49 | 0.44 |
|
EBITDA
|
-9.40 | 265.96 | -0.21 | 2.17 | 0.06 |
|
Depreciation
|
1.81 | 43.29 | 0.00 | 0.07 | 0.01 |
|
EBIT
|
-11.21 | 222.66 | -0.21 | 2.10 | 0.05 |
|
Interest
|
0.02 | 54.39 | 0.00 | 0.77 | 0.01 |
|
Other Income
|
8.21 | 19.24 | 0.46 | 0.04 | 0.00 |
|
Exceptional Items
|
-- | -8.18 | -- | -1.04 | -- |
|
Profit before Tax
|
-3.02 | 179.34 | 0.25 | 0.33 | 0.05 |
|
Provision for Tax
|
0.01 | 33.50 | -- | 0.16 | 0.02 |
|
Profit after Tax
|
-3.04 | 145.84 | 0.25 | 0.17 | 0.03 |
Liabilities (₹ Cr)
| Medi-Caps | Entero Health | Pentokey Organy | Maitri Enterprises | Rubra Medicaments | |
|---|---|---|---|---|---|
|
Shareholder's Funds
|
111.61 | 1,688.61 | 9.46 | 4.70 | 0.56 |
|
Minority Interest
|
-- | 63.94 | -- | -- | -- |
|
Non-Current Liabilities
|
1.14 | 206.12 | -- | 3.85 | 0.00 |
|
Current Liabilities
|
2.71 | 1,587.57 | 0.33 | 7.70 | 0.09 |
|
Total Liabilities
|
115.46 | 3,600.22 | 9.79 | 16.36 | 0.65 |
Assets (₹ Cr)
| Medi-Caps | Entero Health | Pentokey Organy | Maitri Enterprises | Rubra Medicaments | |
|---|---|---|---|---|---|
|
Non-Current Assets
|
68.44 | 1,037.80 | 1.74 | 4.05 | 0.00 |
|
Current Assets
|
47.02 | 2,503.13 | 8.05 | 12.19 | 0.65 |
|
Total Assets
|
115.46 | 3,600.22 | 9.79 | 16.36 | 0.65 |
|
Total Debt*
|
0.00 | 566.68 | 0.00 | 6.89 | 0.00 |
|
Net Current Assets
|
44.31 | 915.56 | 7.72 | 4.49 | 0.56 |
|
Contingent Liabilities
|
-- | 5.51 | 1.72 | 1.79 | -- |
Cashflow (₹ Cr)
| Medi-Caps | Entero Health | Pentokey Organy | Maitri Enterprises | Rubra Medicaments | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
-7.02 | 96.20 | 0.22 | 3.04 | 0.19 |
|
Cash Flow from Investing Activities
|
7.11 | -303.06 | -0.20 | 1.23 | -0.18 |
|
Cash from Financing Activities
|
-- | 123.66 | 0.00 | -4.40 | -- |
|
Net Cash Inflow / Outflow
|
0.09 | -83.20 | 0.01 | -0.12 | 0.01 |
Ratios
Profitability Ratios
| Medi-Caps | Entero Health | Pentokey Organy | Maitri Enterprises | Rubra Medicaments | |
|---|---|---|---|---|---|
|
ROCE (%)
|
-2.58 | 10.93 | 2.66 | 8.25 | 9.64 |
|
ROE (%)
|
-2.61 | 8.57 | 2.62 | 3.66 | 4.66 |
|
ROA (%)
|
-2.52 | 4.68 | 2.55 | 0.89 | 3.22 |
|
EBIT Margin (%)
|
-9.59 | 4.33 | 30.22 | 7.74 | 12.08 |
|
Net Margin (%)
|
-14.70 | 2.21 | 19.02 | 0.59 | 5.07 |
|
Cash Profit Margin (%)
|
-9.88 | 2.87 | 29.75 | 0.85 | 6.64 |
Growth Ratios
| Medi-Caps | Entero Health | Pentokey Organy | Maitri Enterprises | Rubra Medicaments | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
-51.14 | 29.35 | -81.21 | 50.74 | -55.75 |
|
EBIT Growth (%)
|
-229.03 | 35.13 | -71.70 | 487.36 | 78.70 |
|
Net Profit Growth (%)
|
-431.96 | 35.75 | -71.86 | 137.55 | -15.89 |
|
EPS Growth (%)
|
-431.95 | 21.32 | -71.86 | 139.47 | -15.94 |
|
Book Value Growth (%)
|
-7.97 | -2.19 | 2.10 | 3.93 | 4.77 |
Valuation Ratios
| Medi-Caps | Entero Health | Pentokey Organy | Maitri Enterprises | Rubra Medicaments | |
|---|---|---|---|---|---|
|
Price / Earnings
|
0.00 | 47.12 | 80.86 | 64.91 | 275.35 |
|
Price / Book Value
|
0.26 | 3.22 | 2.10 | 2.45 | 12.53 |
|
Dividend Yield (%)
|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
|
EV/EBITDA
|
-23.82 | 20.43 | 59.92 | 8.11 | 115.38 |
|
Market Cap (₹ Cr)
|
28.93 | 5,420.61 | 19.85 | 11.52 | 6.99 |
Solvency Ratios
| Medi-Caps | Entero Health | Pentokey Organy | Maitri Enterprises | Rubra Medicaments | |
|---|---|---|---|---|---|
|
Debt to Equity
|
0.00 | 0.34 | 0.00 | 1.47 | 0.00 |
|
Short term debt to equity ratio
|
-- | 0.26 | -- | 0.62 | -- |
|
Current Ratio
|
17.34 | 1.58 | 24.50 | 1.58 | 6.92 |
|
Quick Ratio
|
16.26 | 1.05 | 23.50 | 0.84 | 6.92 |
|
Interest Coverage
|
-137.05 | 4.30 | 63.95 | 1.43 | 10.12 |
Operating Efficiency Ratios
| Medi-Caps | Entero Health | Pentokey Organy | Maitri Enterprises | Rubra Medicaments | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
55.60 | 18.39 | 35.52 | 18.89 | 57.00 |
|
Asset Turnover
|
0.10 | 2.11 | 0.09 | 1.52 | 0.63 |
|
Receivable days
|
230.34 | 56.56 | 482.34 | 90.06 | 362.19 |
|
Inventory Days
|
90.05 | 41.57 | 144.64 | 77.78 | 0.00 |
|
Payable days
|
71.74 | 34.66 | 44.32 | 86.82 | -- |
|
Cash Conversion Cycle
|
248.65 | 63.47 | 582.66 | 81.03 | -- |